|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.480 USD | +2.29% |
|
-0.48% | -28.12% |
| 07/07 | RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating | MT |
| 03/07 | CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CORMEDIX INC. | Specialty & Advanced Pharmaceuticals | +0.84% | -0.48% | -28.12% | -24.48% | +32.70% | 65Cr |  |  |  |
- Stock Market
- Stocks
- CRMD Stock
- Charts CorMedix Inc.
- Relative Strength Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition